文献速递乳腺技术与安全US

脉冲回波成像测量乳腺声速作为乳腺癌潜在生物标志物

Pulse-Echo Imaging of Breast Speed of Sound as a Potential Biomarker for Breast Cancer.
PubMed 文献 · Ultrasound Med Biol · 2025-07-25

研究利用运动稳健技术连续采集超声图像间的微小错位生成声速图像,以病灶与周围组织的声速对比度预测恶性,在100例乳腺病灶患者中与活检及专家共识金标准比较,声速对比度分类恶性AUC为69.70%。

要点

  • 声速对比度作为乳腺病灶良恶性鉴别指标可行,总体AUC为69.70%。
  • 结合乳腺密度或病灶大小后AUC分别提升至77.40%和78.09%。
  • BI-RADS 4类病灶中,声速对比度在100%特异度时敏感度仅25%。

核心结论

  • 声速对比度作为乳腺病灶鉴别诊断的影像生物标志物具有可行性,但需进一步技术改进以增强病灶分类能力并在超声检查中实现交互式测量。

研究设计与样本

  • 研究纳入100例各类乳腺病灶患者,采用运动稳健技术连续采集超声图像生成声速图像,以活检和专家共识诊断为金标准进行对比。

诊断标准与关键数值

  • 以病灶与周围组织的声速对比度预测恶性,总体恶性分类AUC为69.70%(95%CI 57.4%-81.2%);校正乳腺密度后AUC为77.40%(95%CI 59.2%-93.3%),校正病灶大小后AUC为78.09%(95%CI 56.2%-95.8%);BI-RADS 4类病灶中,100%特异度下敏感度为25%,100%敏感度下特异度为23%。

临床应用与阅片要点

  • 声速对比度目前仅作为研究性生物标志物,在BI-RADS 4类病灶中单独应用敏感度或特异度有限。

局限性

  • 研究指出需进一步技术改进以增强声速成像对病灶的有效分类能力并实现超声检查中的交互式测量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Speed-of-sound (SoS) images, derived from minute misalignments between ultrasound images consecutively acquired using a motion-robust technique, were studied with multi-frame acquisitions to derive a lesion assessment metric for the differential diagnosis of breast cancer.

METHODS: SoS elevation within inclusions was characterized as SoS contrast by comparing inclusions with their surrounding tissue. Malignancy was predicted as having larger SoS contrast compared with benign inclusions. In a study involving 100 patients with various breast lesion types, the findings were compared with gold standard diagnoses based on biopsy and expert consensus.

RESULTS: The proposed SoS contrast metric achieved an overall malignancy classification with an area under the curve of 69.70% (95% confidence interval [CI]: 57.4%-81.2%), with results varying depending on lesion type. Accounting for breast density or lesion size improved the area under the curve to 77.40% (95% CI: 59.2%-93.3%) and 78.09% (95% CI: 56.2%-95.8%), respectively. Focusing on Breast Imaging Reporting and Data System 4 lesions, where mammography and B-mode imaging are inconclusive, a sensitivity of 25% at 100% specificity or a specificity of 23% at 100% sensitivity was attained.

CONCLUSION: This study highlights the feasibility of SoS contrast as an imaging biomarker for the differential diagnosis of breast lesions. It also indicates the need for further technical advancements in SoS imaging to strengthen its ability to effectively classify lesions and enable interactive measurements during ultrasound examinations.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Schweizer D, Farkas M, Bezek CD, et al. Pulse-Echo Imaging of Breast Speed of Sound as a Potential Biomarker for Breast Cancer. Ultrasound Med Biol. 2025. PMID: 40713236. doi:10.1016/j.ultrasmedbio.2025.07.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。